NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
06/25/2024
Back to search
Official data from USPTO
QUANTIFERON MONITOR
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
QUANTIFERON MONITOR
ST13
US500000086390834Class
1, 5
Filing
86390834
Registration
5370363
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
43
Latest update
06/25/2024
Trademark type
Word
Nice classes
1, 5
Filing date
09/10/2014
Registration date
01/02/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/25/2024
Last transaction
06/25/2024
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
First use anywhere
2014-11-00
First use in commerce
2014-11-00
Drawing code
4
Owner type
11
Owner location
Chadstone, Victoria, AU
Examiner
KING, LINDA
Current location
Historical data usage
Holders and representatives
Holders
Cellestis Limited
Representatives
Victoria Friedman Dennemeyer & Associates, LLC
Technical classification
Nice Classes
Class 1Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemical preparations for use in industry or research use; chemical reagents for non-medical purposes; chemical reagents for use in the preparation of in vitro diagnostic kits; biological preparations for use in scientific and laboratory research; biological preparations for use in the preparation of in vitro diagnostic kits for scientific research or laboratory use; chemical test kits for in vitro detection of interferon-gamma for laboratory or research use; biochemicalsmonoclonal antibodies for in vitro scientific or research use
Class 5
Pharmaceutical preparations to measure responses to innate and adaptive immune stimulants; chemical and biological peptides for medical diagnostic use; chemical and biological antigens for medical diagnostic use; hormones and glycoproteins for medical or medical diagnostic purposes; immunoglobulin and blood coagulation factors and blood growth factors for medical or medical diagnostic purposes; chemical reagents for medical or medical diagnostic purposes; in vitro diagnostic test kits for use in detecting infection and cell mediated immune response
Publications
History of USPTO decisions and trademark events.
43 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
06/25/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/25/2024
E815
TEAS SECTION 8 & 15 RECEIVED
12/14/2023
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
01/02/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
01/02/2018
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
11/30/2017
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
11/29/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/29/2017
GNRT
NON-FINAL ACTION E-MAILED
11/29/2017
CNRT
SU - NON-FINAL ACTION - WRITTEN
11/29/2017
SUPC
STATEMENT OF USE PROCESSING COMPLETE
11/21/2017
IUAF
USE AMENDMENT FILED
10/20/2017
EISU
TEAS STATEMENT OF USE RECEIVED
10/20/2017
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04/22/2017
EX3G
SOU EXTENSION 3 GRANTED
04/20/2017
EXT3
SOU EXTENSION 3 FILED
04/20/2017
EEXT
SOU TEAS EXTENSION RECEIVED
04/20/2017
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/08/2016
EX2G
SOU EXTENSION 2 GRANTED
11/07/2016
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
11/07/2016
EXT2
SOU EXTENSION 2 FILED
10/20/2016
EEXT
SOU TEAS EXTENSION RECEIVED
10/20/2016
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04/22/2016
EX1G
SOU EXTENSION 1 GRANTED
04/20/2016
EXT1
SOU EXTENSION 1 FILED
04/20/2016
EEXT
SOU TEAS EXTENSION RECEIVED
04/20/2016
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
10/20/2015
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/25/2015
PUBO
PUBLISHED FOR OPPOSITION
08/25/2015
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/05/2015
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
07/20/2015
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/17/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/15/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/15/2015
ALIE
ASSIGNED TO LIE
07/08/2015
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/29/2015
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/29/2014
GNRT
NON-FINAL ACTION E-MAILED
12/29/2014
CNRT
NON-FINAL ACTION WRITTEN
12/29/2014
DOCK
ASSIGNED TO EXAMINER
12/22/2014
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/18/2014
NWAP
NEW APPLICATION ENTERED
09/13/2014
Continuous trademark protection
Get notified about every new filing that threatens QUANTIFERON MONITOR or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.